Representative Jackson Disposes $15,001–$50,000 in Robinhood Markets Stock via Morgan Stanley Trust Account
Representative Jonathan L. Jackson sold between $15,001 and $50,000 of Robinhood Markets stock on December 22, according to a January 8 filing. The transaction was executed through his Morgan Stanley Trust Account and is his latest reported disposition of HOOD shares.
1. Congressional Insider Sale Raises Governance Questions
In a Form 4 filing disclosed on January 8, Representative Jonathan L. Jackson (D-Illinois) reported the sale of between $15,001 and $50,000 worth of Robinhood Markets stock on December 22. The transaction was executed through his Morgan Stanley Trust Account, marking one of several high-profile trades the freshman congressman has made in recent months. While such disclosures are routine under the STOCK Act, the sale highlights ongoing scrutiny of lawmaker transactions in companies that dominate retail trading volumes and raises questions about potential conflicts of interest in the policymaking process.
2. Robust Q3 Performance Underscores Revenue Diversification
Robinhood Markets delivered $1.27 billion in revenue for Q3, doubling year-over-year and topping consensus by approximately $120 million. The firm reported non-GAAP earnings per share of $0.61, beating analyst estimates by $0.20, while net margin reached 52.2% and return on equity stood at 21.7%. Transaction-based revenue surged 129%, driven by a more than fourfold increase in crypto trading revenue, and interest income climbed 66% as client cash balances expanded. These results underscore Robinhood’s progress in diversifying beyond equity trading into high-growth segments such as crypto and event contracts.
3. Mixed Analyst Ratings and Price Targets Signal Cautious Optimism
Institutional research coverage remains broadly positive but tempered by valuation concerns. Argus initiated coverage with a Buy rating and a $145 target, while Barclays maintained an Overweight stance but trimmed its target to $159. Bank of America set a Buy rating with a $154 objective after reducing its target, and Goldman Sachs reiterated its Buy recommendation. Conversely, Zacks downgraded the shares from Strong-Buy to Hold, reflecting near-term headwinds from regulatory scrutiny and elevated insider selling. The consensus Moderate Buy rating across 25 analysts and a mean target of $136.62 imply mid-teens upside, suggesting cautious optimism among equity strategists.